Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
Novavax Could Deliver 100M Covid-19 Vaccine Doses By End of Year, Says R&D Head
Posted
May 14, 2020
Views
10,070
Likes
116
Comments
14
Engagement
May 14, 2020
10,070
116
14
1.29%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
10:35Now PlayingMay.14 -- Novavax Inc.'s vaccine is one of at least 100 potential candidates trying to curb the spread of the virus that causes Covid-19. The biotech company recently received a funding of $388-million from the Coalition for Epidemic Preparedness Innovation, making it the biggest investment ever from the group. Dr. Gregory Glenn, Novavax's president of research and development, speaks on "Bloomberg Technology."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
